A detailed history of Thrivent Financial For Lutherans transactions in Danaher Corp stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 730,695 shares of DHR stock, worth $183 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
730,695
Previous 764,740 4.45%
Holding current value
$183 Million
Previous $177 Million 3.14%
% of portfolio
0.37%
Previous 0.39%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$224.58 - $256.19 $7.65 Million - $8.72 Million
-34,045 Reduced 4.45%
730,695 $182 Million
Q4 2023

Feb 14, 2024

BUY
$185.1 - $233.13 $12.1 Million - $15.2 Million
65,191 Added 9.32%
764,740 $177 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $15.3 Million - $17.5 Million
65,742 Added 10.37%
699,549 $174 Million
Q2 2023

Aug 14, 2023

SELL
$224.99 - $256.14 $2.84 Million - $3.23 Million
-12,608 Reduced 1.95%
633,807 $152 Million
Q1 2023

May 17, 2023

SELL
$239.75 - $277.0 $9.23 Million - $10.7 Million
-38,481 Reduced 5.62%
646,415 $163 Million
Q4 2022

Feb 08, 2023

SELL
$241.42 - $282.29 $2.13 Million - $2.49 Million
-8,833 Reduced 1.27%
684,896 $182 Million
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $29.3 Million - $179 Million
118,706 Added 20.64%
693,729 $179 Million
Q2 2022

Aug 16, 2022

SELL
$237.11 - $299.66 $6.34 Million - $8.01 Million
-26,739 Reduced 4.44%
575,023 $146 Million
Q1 2022

May 13, 2022

BUY
$257.27 - $315.76 $3.84 Million - $4.71 Million
14,914 Added 2.54%
601,762 $177 Million
Q4 2021

Feb 16, 2022

BUY
$292.08 - $329.01 $25.7 Million - $29 Million
88,050 Added 17.65%
586,848 $192 Million
Q3 2021

Nov 15, 2021

BUY
$272.21 - $332.43 $108 Million - $132 Million
396,900 Added 389.51%
498,798 $152 Million
Q2 2021

Sep 24, 2021

BUY
$225.08 - $271.69 $1.14 Million - $1.38 Million
5,075 Added 5.24%
101,898 $27.3 Million
Q2 2021

Aug 19, 2021

BUY
$225.08 - $271.69 $138,874 - $167,632
617 Added 0.64%
96,823 $26 Million
Q1 2021

May 17, 2021

SELL
$212.38 - $245.9 $22.6 Million - $26.2 Million
-106,481 Reduced 52.53%
96,206 $21.7 Million
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $8.98 Million - $10.4 Million
-42,258 Reduced 17.25%
202,687 $45 Million
Q3 2020

Nov 10, 2020

SELL
$177.16 - $215.33 $8.18 Million - $9.95 Million
-46,200 Reduced 15.87%
244,945 $52.7 Million
Q2 2020

Aug 12, 2020

BUY
$128.7 - $176.83 $654,954 - $899,887
5,089 Added 1.78%
291,145 $51.4 Million
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $14.8 Million - $20.7 Million
-122,320 Reduced 29.95%
286,056 $39.6 Million
Q4 2019

Feb 13, 2020

SELL
$133.47 - $153.48 $392,535 - $451,384
-2,941 Reduced 0.72%
408,376 $62.7 Million
Q3 2019

Nov 14, 2019

SELL
$135.4 - $146.47 $1.44 Million - $1.56 Million
-10,656 Reduced 2.53%
411,317 $59.4 Million
Q2 2019

Aug 13, 2019

SELL
$124.88 - $143.73 $4.47 Million - $5.14 Million
-35,789 Reduced 7.82%
421,973 $60.3 Million
Q1 2019

May 14, 2019

SELL
$97.62 - $132.29 $9.49 Million - $12.9 Million
-97,217 Reduced 17.52%
457,762 $60.4 Million
Q4 2018

Feb 15, 2019

SELL
$94.85 - $109.54 $16.4 Million - $19 Million
-173,367 Reduced 23.8%
554,979 $57.2 Million
Q3 2018

Nov 15, 2018

SELL
$98.13 - $108.9 $9.48 Million - $10.5 Million
-96,645 Reduced 11.71%
728,346 $79.1 Million
Q2 2018

Aug 14, 2018

BUY
$96.1 - $103.24 $54.3 Million - $58.3 Million
565,160 Added 217.51%
824,991 $81.4 Million
Q1 2018

May 08, 2018

BUY
$92.16 - $103.8 $9.38 Million - $10.6 Million
101,731 Added 64.35%
259,831 $25.4 Million
Q4 2017

Feb 14, 2018

BUY
$85.26 - $94.62 $6.41 Million - $7.11 Million
75,140 Added 90.57%
158,100 $14.7 Million
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $6.58 Million - $7.34 Million
82,960
82,960 $7.12 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $182B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.